Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2022-06-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of invention patent certificates. It details patent numbers, inventors, application dates, and the impact of these patents on the company's products. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, or any other report types such as annual reports or earnings releases. The document is an official announcement about intellectual property achievements, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about patents, which falls under the general category of Regulatory Filings (RNS) as it does not fit any other specific category.
2022-06-24 Chinese
关于持股5%以上股东及一致行动人减持股份变动达到1%暨减持计划实施完毕的公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement regarding the reduction of shareholdings by shareholders holding more than 5% of the company's shares, including specifics on the number of shares reduced, dates, methods of reduction, and compliance with relevant securities laws and regulations. It includes tables showing shareholding changes before and after the reduction, and confirms that the reduction plan has been completed. The content focuses on shareholding changes by major shareholders and their compliance disclosures, which aligns with the definition of Major Shareholding Notification filings. There is no indication that this is a full financial report, earnings release, or other types of filings. The document length and detail confirm it is not a brief announcement or a certification letter, but a substantive notification of shareholding changes.
2022-06-24 Chinese
关于持股5%以上股东及一致行动人减持股份进展的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of shareholding reduction by shareholders holding more than 5% of the company's shares. It details specific share transactions, percentages of total share capital reduced, compliance with relevant securities laws and regulations, and includes tables summarizing the share reduction activities. There is no financial performance data, earnings information, or management discussion. The content focuses on changes in major shareholdings and disclosures related to those changes. Therefore, this document fits the category of Major Shareholding Notification (MRQ). The document length is about 4898 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement.
2022-06-17 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Jilin Province Drug Administration). It details the registration certificates obtained, their validity periods, and product descriptions. The document is short (2020 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed filing. There is no financial data, no mention of annual or quarterly results, no management discussion, no audit information, or other report types. It is a regulatory announcement about product registration status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-06-17 Chinese
关于持股5%以上股东及一致行动人累计减持股份达到1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an official announcement regarding the reduction of shareholdings by shareholders holding more than 5% of the company's shares. It details the shareholders' names, the number of shares reduced, the methods of reduction (block trades), and compliance with relevant securities laws and regulations. It includes specific dates, share quantities, and confirms that the reduction is consistent with previously disclosed plans. There is no financial statement or report content, but rather a regulatory disclosure about shareholding changes. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2022-06-07 Chinese
2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2021 annual equity distribution (dividend) by the company. It details the dividend amount per share, the total dividend payout, the record date, the ex-dividend date, and the method of dividend distribution. It also references the approval of the dividend plan at the 2021 annual general meeting. The document does not contain financial statements or detailed financial performance data but focuses on the dividend payment details and related shareholder information. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2022-05-23 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.